# Specification Quality Checklist: SBML and BioPAX built from the graph

**Purpose**: Validate specification completeness and quality before proceeding to planning
**Created**: 2026-10-23
**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs)
- [x] Focused on user value and business needs
- [x] Written for non-technical stakeholders
- [x] All mandatory sections completed

## Requirement Completeness

- [x] No [NEEDS CLARIFICATION] markers remain
- [x] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria are technology-agnostic (no implementation details)
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified
- [x] Scope is clearly bounded
- [x] Dependencies and assumptions identified

## Feature Readiness

- [x] All functional requirements have clear acceptance criteria
- [x] User scenarios cover primary flows
- [x] Feature meets measurable outcomes defined in Success Criteria
- [x] No implementation details leak into specification

## Notes

- As in specs 010-014, the spec names the services and gates the work concerns (the node content service, nginx and the dev proxy, spec 011's cache labels).
- **Rewritten 24 Oct 2026.** The spec now names the two exporter repositories, because which code is the single implementation is the user's decision and the feature's whole point ("What changed"). It still names no code structure inside them; that is the plan's.
- No clarification markers. Where BioPAX is served, the generation note, and Level 2's fate are recorded as assumptions or tasks, each with a default.
- **Revalidated after the rewrite: all items pass.** Naming the repositories is a scope statement, not an implementation detail.
